Literature DB >> 22031471

Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration.

Quentin Rainer1, Hai T Nguyen, Gaël Quesseveur, Alain M Gardier, Denis J David, Bruno P Guiard.   

Abstract

Most preclinical studies investigating the effects and the mechanism of action of antidepressants have been performed in naive rodents. This is inappropriate because antidepressants act on specific symptoms of the pathological condition, such as distress and anxiety. We have developed a mouse model of anxiety/depression based on addition of corticosterone to drinking water. This model is highly reproducible and easy to set up compared with unpredictable chronic mild stress. The serotonin 1A (5-HT(1A)) autoreceptor is known to play a role in mood disorders and their treatments. An increase in somatodendritic 5-HT(1A) autoreceptor density in the dorsal raphe (DR) attenuates the therapeutic activity of selective serotonin-reuptake inhibitors (SSRIs), whereas their functional desensitization promotes activation of brain serotonergic transmission, thereby representing an adaptive change relevant to their therapeutic effect. Here we assessed the effects of sustained administration of the SSRI fluoxetine on 5-HT(1A) autoreceptor sensitivity in mice administered with corticosterone. Fluoxetine attenuated hypothermia induced by the 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin, decreased DR 5-HT neuronal activity, and decreased 5-HT release in both vehicle- and corticosterone-pretreated mice. However, such desensitization was more pronounced in corticosterone-pretreated mice. This change had an overall effect on serotonergic tone because we found a greater firing rate of 5-HT neurons associated with an enhancement of 5-HT outflow in the DR of corticosterone-pretreated mice in response to fluoxetine compared with the corresponding group of vehicle-pretreated mice. These results provide cellular explanations for the antidepressant effects produced by SSRIs in subjects with pathological conditions but not in naive animals or healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031471     DOI: 10.1124/mol.111.075796

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Delayed Antidepressant Efficacy and the Desensitization Hypothesis.

Authors:  Kathryn G Commons; Sofia E Linnros
Journal:  ACS Chem Neurosci       Date:  2019-03-11       Impact factor: 4.418

Review 2.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

3.  High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice.

Authors:  Juliane Zemdegs; Gaël Quesseveur; David Jarriault; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  Br J Pharmacol       Date:  2015-12-09       Impact factor: 8.739

4.  5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.

Authors:  G Quesseveur; C Repérant; D J David; A M Gardier; C Sanchez; B P Guiard
Journal:  Exp Brain Res       Date:  2013-02-15       Impact factor: 1.972

5.  Activation of postsynaptic 5-HT1A receptors improve stress adaptation.

Authors:  Jiansong Zhou; Xia Cao; Adam C Mar; Yu-Qiang Ding; Xiaoping Wang; Qi Li; Lingjiang Li
Journal:  Psychopharmacology (Berl)       Date:  2013-11-21       Impact factor: 4.530

6.  Sex and social status modify the effects of fluoxetine on socioemotional behaviors in Syrian hamsters and rhesus macaques.

Authors:  Dené A Voisin; Alison Wakeford; Jonathon Nye; Jiyoung Mun; Sara R Jones; Jason Locke; Kim L Huhman; Mark E Wilson; H Elliott Albers; Vasiliki Michopoulos
Journal:  Pharmacol Biochem Behav       Date:  2022-02-24       Impact factor: 3.533

Review 7.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

8.  Positive regulation of raphe serotonin neurons by serotonin 2B receptors.

Authors:  Arnauld Belmer; Emily Quentin; Silvina L Diaz; Bruno P Guiard; Sebastian P Fernandez; Stéphane Doly; Sophie M Banas; Pothitos M Pitychoutis; Imane Moutkine; Aude Muzerelle; Anna Tchenio; Anne Roumier; Manuel Mameli; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

9.  Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.

Authors:  Francis L Pazini; Mauricio P Cunha; Julia M Rosa; André R S Colla; Vicente Lieberknecht; Ágatha Oliveira; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.590

10.  BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.

Authors:  G Quesseveur; D J David; M C Gaillard; P Pla; M V Wu; H T Nguyen; V Nicolas; G Auregan; I David; A Dranovsky; P Hantraye; R Hen; A M Gardier; N Déglon; B P Guiard
Journal:  Transl Psychiatry       Date:  2013-04-30       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.